Sign In
Buy CVS
CVS Health Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -94.17. In total, the insiders bought 1.42B and sold 3.98M CVS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-94.17 |
| ● Buy | 1.42B shares |
| ● Sell | 3.98M shares |
|
67% Buy Activity
Moderate Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Apr 01, 2026 Sell |
Joyner J. David President, CEO And Chair |
8 029 Value: $582.0K |
||
|
Apr 01, 2026 Sell |
Khichi Samrat S. EVP, Cpo And General Counsel |
3 541 Value: $256.7K |
||
|
Apr 01, 2026 Sell |
Mandadi Tilak EVP, Chief Exp & Tech Officer |
3 634 Value: $263.4K |
||
|
Apr 01, 2026 Sell |
Shah Prem S EVP And Group President |
1 484 Value: $107.6K |
||
|
Apr 01, 2026 Sell |
Nelson Steven H EVP And President, Aetna |
2 432 Value: $176.3K |
||
|
Apr 01, 2026 Sell |
Clark James David SVP, Cont & Chief Acct Officer |
3 262 Value: $236.5K |
||
|
Apr 01, 2026 Sell |
Capozzi Heidi B EVP And Chief People Officer |
1 334 Value: $96.7K |
||
|
Mar 31, 2026 Buy |
Compton-phillips Amy EVP, Chief Medical Officer |
35 928 Value: $2.58M |
||
|
Mar 31, 2026 Buy |
Joyner J. David President, CEO And Chair |
86 326 Value: $6.20M |
||
|
Mar 31, 2026 Buy |
Khichi Samrat S. EVP, Cpo And General Counsel |
12 531 Value: $900.0K |
||
|
Mar 31, 2026 Buy |
Khichi Samrat S. EVP, Cpo And General Counsel |
80 838 Value: $5.81M |
||
|
Mar 31, 2026 Buy |
Shah Prem S EVP And Group President |
161 676 Value: $11.6M |
||
|
Mar 31, 2026 Buy |
Shah Prem S EVP And Group President |
25 062 Value: $1.80M |
||
|
Mar 31, 2026 Buy |
Newman Brian EVP, Chief Financial Officer |
125 748 Value: $9.03M |
||
|
Mar 31, 2026 Buy |
Newman Brian EVP, Chief Financial Officer |
19 493 Value: $1.40M |
||
|
Mar 31, 2026 Buy |
Nelson Steven H EVP And President, Aetna |
143 712 Value: $10.3M |
||
|
Mar 31, 2026 Buy |
Nelson Steven H EVP And President, Aetna |
22 277 Value: $1.60M |
||
|
Mar 31, 2026 Buy |
Mandadi Tilak EVP, Chief Exp & Tech Officer |
143 712 Value: $10.3M |
||
|
Mar 31, 2026 Buy |
Mandadi Tilak EVP, Chief Exp & Tech Officer |
22 277 Value: $1.60M |
||
|
Mar 31, 2026 Buy |
Compton-phillips Amy EVP, Chief Medical Officer |
5 569 Value: $400.0K |
||
|
Mar 31, 2026 Buy |
Clark James David SVP, Cont & Chief Acct Officer |
11 138 Value: $799.9K |
||
|
Mar 31, 2026 Buy |
Clark James David SVP, Cont & Chief Acct Officer |
11 976 Value: $860.1K |
||
|
Mar 31, 2026 Buy |
Capozzi Heidi B EVP And Chief People Officer |
10 025 Value: $720.0K |
||
|
Mar 31, 2026 Buy |
Capozzi Heidi B EVP And Chief People Officer |
64 670 Value: $4.64M |
||
|
Mar 19, 2026 Buy |
Gallina John E Director |
582 Value: $41.8K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
